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Abstract
Background: Over the last decade, cholera outbreaks in parts of Kenya have become common. Although
a number of recent studies describe the epidemiology of cholera in Kenya, there is paucity of information
concerning the diversity and occurrence of mobile genetic elements in Vibrio cholerae strains implicated in
these outbreaks. A total of 65 Vibrio cholerae O1 El Tor serotype Inaba isolated between 1994 and 2007
from various outbreaks in Kenya were investigated for mobile genetic elements including integrons,
transposons, the integrating conjugative elements (ICEs), conjugative plasmids and for their genotypic
relatedness.
Results: All the strains were haemolytic on 5% sheep blood and positive for the Vibrio cholerae El Tor-
specific haemolysin toxin gene (hylA) by PCR. They all contained strB, sulII, floR and the dfrA1 genes encoding
resistance to streptomycin, sulfamethoxazole, chloramphenicol and trimethoprim respectively. These
genes, together with an ICE belonging to the SXT/R391 family were transferable to the rifampicin-resistant
E. coli C600 en bloc. All the strains were negative for integron class 1, 2 and 3 and for transposase gene of
transposon Tn7 but were positive for integron class 4 and the trpM gene of transposon Tn21. No plasmids
were isolated from any of the 65 strains. All the strains were also positive for all V. cholera El Tor
pathogenic genes except the NAG- specific heat-stable toxin (st) gene. None of the strains were positive
for virulence genes associated with the V. cholerae classical biotype. All the strains were positive for El Tor-
specific CTXphi bacteriophage rstrR repressor gene (CTXETΦ) but negative for the Classical, Calcutta, and
the Environmental repressor types. Pulse Field Gel Electrophoresis (PFGE) showed that regardless of the
year of isolation, all the strains bearing the SXT element were clonally related.
Conclusions: This study demonstrates that the V. cholerae O1 strains carrying an SXT/R391-like element
implicated in recent cholera outbreaks in Kenya has not changed significantly between 1994 and 2007 and
are clonally related.
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Since 1971, Kenya has suffered many outbreaks of chol-
era. From 1974 to 1989, outbreaks were reported every
year with an average case fatality rate of 3.6% [1]. For
instance, the 1994 cholera outbreaks started in Kwale on
the Kenyan coastline and affected 3 districts in the Coast
province; Kwale, Mombasa and Taita-Taveta. Between
1997 and 1999, more than 33,400 notified cases of chol-
era were reported in Kenya, representing 10% of all chol-
era cases reported from the African continent during this
period [2,3]. From 2000 to 2006, cases ranging from 816
to 1,157 were reported each year except for 2002, in which
291 cases were reported [1]. More cases have been
reported locally since 2005 [4] and the recent outbreak in
2007 had a case fatality of up to 5.6% [1].
Strains belonging to serotype Ogawa were frequently iso-
lated from cholera outbreaks in Kenya in the 1970s
through 1990s and many isolates from this period were
known to exhibit resistance to a diverse range of antibiot-
ics including chloramphenicol, tetracycline, ampicillin,
streptomycin, sulfonamides and doxycycline [5,6]. In the
recent past however, serotype Inaba has emerged as the
main cause of epidemics in Kenya and these isolates are
frequently not susceptible to chloramphenicol, strepto-
mycin, sulphonamides, sulfamethoxazole and trimetho-
prim (Chl-Str-Sul-Trim). A mobile genetic element (MGE)
belonging to the SXT family of ICEs, was shown to confer
this phenotype in the strains isolated during the 1998-
1999 period [7]. It is however unknown if strains isolated
prior to and after this period harbour this element.
The integrase gene of the SXT family of ICEs is highly
related to the one found in the R391 element [8] and is
also closely related to the one found in conjugative trans-
posons and bacteriophages [9]. Upon conjugation, SXT/
R391-like ICEs integrate into the prfC, a gene found on the
large V. cholerae chromosome [10]. In the SXT-like ele-
ments, genes encoding antibiotic resistance are integrated
into the rumB thus interrupting the rumAB operon while
in the R391, this operon is not interrupted [11,12]. An
SXT element, SXTMO10, was detected in V. cholerae from a
O139 biotype strain from Madras, India and is known to
confer the Chl-Str-Sul-Trim phenotype [12]. This element
is related to ICEVchInd1 found in O139 and El Tor strains
[12,13]. Burrus et al. (2006) gave a detailed review of the
ICE biology and classification [14]. We investigated 65
strains exhibiting the Chl-Str-Sul-Trim phenotype isolated
from various parts of Kenya from 1994 through 2007 for
the presence of SXT/R391-like elements and for evidence
of integration of the element into the host chromosome.
We also determined the diversity of rstR genes encoding
the cholera CTX-prophage repressor from the 65 strains
isolated from the same period. Although most sequences
in the CTXΦ-prophage genomes are similar in the El Tor
and Classical biotypes strains, the rstR specific to the bio-
type-specific prophages differ. The El Tor and Classical
biotype strains carry the CTXETΦ and the CTXClassΦ repres-
sor types, respectively [15,16] while the CTXCalcΦ and
CTXEnvΦ encode the Calcutta and Environmental rstR
types, respectively [17,18]. Strains known as the Matlab
variants belonging to the El Tor biotype but harbouring
the CTXclassΦ prophage have been isolated in Bangladesh
[19], India [20] and Mozambique [21]. Three classes of
multiresistant (MR) integrons (class 1, 2 and 3) are
known to harbour genes encoding resistance to antibiot-
ics [22-24]. Integron class 4 is commonly found in V. chol-
erae and is referred to as a super integron (SI). Although
integrons are not capable of self-transposition, they are
known to associate with insertion sequences (ISs), trans-
posons, and/or conjugative plasmids which serve as vehi-
cles for the intra- and interspecies transmission of genetic
material [24]. Like the R391 ICE elements, transposon
Tn21 and its relatives frequently harbour genes conferring
resistance to mercury and antibiotics-containing inte-
grons that integrate into the left arm adjacent to the tnpM
gene [25]. Transposon Tn7 is also known to associate with
integron class 2 and is therefore an important MGE [26].
We therefore also analysed the 65 strains for the presence
of integron classes 1, 2, 3 and 4, conjugative plasmids, the
tnpM gene of transposon Tn21 and the transposase of Tn7
transposon.
Methods
Sources of Vibrio cholerae strains
Strains that were included in this study were obtained
from distinct outbreaks occurring in different parts of
Kenya between 1994 and 2007 as indicated in figure 1.
For consistency, a distinct outbreak was defined as a gap
of at least 2 months between the last known cholera case
and a report of a new case in the same location. Archived
isolates were initially subcultured on thiosulphate citrate
bile salts sucrose agar (TCBS) and confirmation of strain
identity was done by serology using polyvalent, anti-
Ogawa, and anti-Inaba antisera (Denka Seiken, Tokyo,
Japan). Haemolysis test was done by growing V. cholerae
on 5% sheep blood nutrient agar plates incubated at 37°C
overnight.
Antimicrobial susceptibility testing
Antimicrobial susceptibility tests were performed using
commercial discs following manufacturer's instructions
(Cypress diagnostics, Langdorp, Belgium). Susceptibility
to β-lactam antibiotics was tested using ampicillin (10 μg)
while susceptibility to cephalosporins was determined
using cefixime (30 μg), cefotaxime (30 μg), cefepime (30
μg) cefoxitin (30 ug), cefuroxime (30 ug), ceftriaxone (30
ug), and ceftazidime (30 ug). Ciprofloxacin (5 μg), nor-
floxacin (10 μg) and nalidixic acid (30 μg) were used forPage 2 of 8
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μg), a monobactam antibiotic, was also included in the
assay. Aminoglycosides used in susceptibility tests
included kanamycin (30 μg), amikacin (30 μg), strepto-
mycin (30 μg), gentamicin (10 μg), neomycin (30 μg),
and tobramycin (10 μg). Tetracycline antibiotics included
minocycline (30 μg), doxycycline (30 μg) and tetracycline
(30 μg). Other antibiotics included chloramphenicol (30
μg), furazolidone (50 μg), rifampicin (30 μg) and nitro-
furantoin (30 μg). Sulphamethoxazole (25 μg), trimetho-
prim (5.2 μg) and sulphonamides (300 μg) were also
tested. β-lactam and β-lactamase inhibitor combinations
included augmentin (comprising 20 μg amoxicillin and
10 μg clavulanic acid) and a combination of piperacillin
(100 μg) and tazobactam (10 μg). E. coli ATCC 25922 was
used as a control for bacterial growth and potency of anti-
biotic discs. Susceptibility tests were interpreted using the
Clinical and Laboratory Standards Institute guidelines
[27].
PCR amplification
DNA used as template for PCR reactions was prepared
from overnight L-broth cultures incubated at 37°C. Bacte-
rial cells were harvested by centrifugation and re-sus-
pended in 1 ml 10 mM Tris/HCl (pH8·0) containing 1
mM EDTA. Template DNA was obtained by boiling for 10
min and separated by centrifugation at 12,000 × g for 3
min and then stored at -20°C until analysed. PCR was car-
ried out in 50 μl reaction volumes containing 5 μl 10×
concentrated PCR buffer [100 mM Tris/HCl (pH8·3), 500
mM KCl, 15 mM MgCl2], 5 μl (10 pmol μl-1) each of
primer, 4 μl dNTP mix (2·5 mM each dNTP), 0.25 μl (5
U μl-1) Taq DNA polymerase, 5 μl of template DNA and
25.75 μl sterilized distilled water. All PCR assays were per-
formed using an automated thermal cycler (GeneAmp
PCR System 9700; Applied Biosystems). PCR products
were analysed by electrophoresis in 1.5% agarose gels,
stained with ethidium bromide, visualized under UV light
and recorded with the aid of a gel documentation system
(Bio-Rad Laboratories, Hercules, Ca, USA)
Sources of V. cholera strains used for this studyFigur  1
Sources of V. cholera strains used for this study. The geographic locations from which the isolates were obtained are 
indicated using a black dot. The number of the strains and the year of isolations are also indicated. All the strains from various 
regions regardless of the year of isolation had an identical profile for antibiotic susceptibility profiles and for genes associated 
with resistance and virulence in V. cholerae.
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resistance genes
The mating assays were carried using the rifampicin-resist-
ant E. coli C600 strain as the recipient. Conjugations were
carried out at 37°C for 8 hr without shaking. Transconju-
gants were selected on Mueller-Hinton agar plates (Oxoid
Ltd; Basingstoke, Hampshire, England) containing tri-
methoprim (5.2 μg/ml) and rifampicin 30 μg/ml. In order
to confirm that the antibiotic resistance gene markers
were transferred during conjugation, the donor and
transconjugants were analysed using PCR methods.
Screening of the sulII gene encoding resistance to sulfam-
ethoxazole, dfrA1 encoding resistance to trimethoprim
and strB encoding resistance to streptomycin was done as
described previously by Ramachandran et al. [28] while
detection of the floR conferring resistance to chloram-
phenicol and dfrA-18 gene that also confers resistance to
trimethoprim was done as described previously [7,12].
Genomic DNA from V. cholerae O139 strains ATCC
51394, CO594 and VO143 were used as positive controls
templates for the screening of sulII, dfr18, strB and SXT
respectively and that from O1 biotype El Tor strains
KO194 was used for the screening for the dfrA1 gene.
Detection of mobile genetic elements
All strains were further tested for the presence of the 3'-
conserved sequence (3-CS) of integron class 1 using the
forward primer targeting the qacEΔ1 and the reverse
primer of the sulI1 gene encoding resistance to quaternary
ammonium compounds (detergents) and sulphona-
mides, respectively. The gene cassettes flanked by the 5'-
CS and the 3'-CS were amplified using a combination of
primers that target the 3'-CS and the 5'-CS of the integron
class 1. Primers and PCR conditions for the detection of
intI1 gene belonging to integron class 1 was done as
described previously by Rivera et al. [29] while detection
of the 3'-CS and the variable cassette region was done as
described previously by Dalsgaard et al. [30]. Detection of
intI2 was performed as previously described by Falbo et al.
[31]. Screening for the integrase specific to integron class
3 (intI3) and integron class 4 (intI4) was performed as
detailed previously by Machado et al. and Shi et al. respec-
tively [32,33].
We also conducted PCR experiments using the genomic
DNA isolated from donors and transconjugants to verify
the transfer of the Tn21 and the SXT/R391-like element.
Detection of Tn21 transposon was done using trpM-spe-
cific primers and PCR conditions published previously by
Villa et al. [34] while detection of Tn7 was done using PCR
conditions and primers described previously by Hansson
et al. [26]. The presence of the ICE was detected using
primers for amplification of a 1035 bp fragment of the
integrase gene specific for the SXT/R391-like element as
described previously by Bhanumathi et al. [35]. Integra-
tion of the ICE into the chromosome was demonstrated
by amplification of a PCR product of 825 bp correspond-
ing to the right junction between the attP element of the
ICE and the prfC chromosomal gene of the bacteria. Prim-
ers and PCR conditions used are similar to those pub-
lished before by Pugliese et al. [7]. Strains from our culture
collection known to harbour various genes of interest
were used as appropriate positive controls in correspond-
ing PCR experiments.
Analysis of Vibrio cholerae virulence genes
All strains were screened for the presence of genes encod-
ing virulence determinants in V. cholerae including chol-
era toxin (ctxA), zonula occludens toxin (zot), accessory
cholera enterotoxin (ace), hemolysin (hlyA), and NAG-
specific heat-stable toxin (st). Detection of the tcpA gene
specific to the El Tor and Classical biotypes was done
using a common forward primer and biotype-specific
reverse primers. Similarly, two forward primers were used
for the detection of the biotype-specific haemolysin gene
(hylA). PCR conditions and primers used for the detection
of tcpA, ompU, tcpI, toxR and hylA genes were similar to
those described previously by Rivera et al. [29] while
detection of the ctxA gene was done using primers and
conditions described before by Fields et al. [36]. Genomic
DNA from V. cholerae O139 strain ATCC 51394 was used
as a positive control in screening for ctxA, zot, ace, tcpA,
ompU, tcpI, and toxR genes. For detection of the four rstR
gene alleles, a single reverse primer was used in combina-
tion with forward primers specific for each of the four rstR
gene alleles as described previously by Nusrin et al. [37].
Plasmid analysis
DNA for plasmid analysis was extracted using the method
of Kado and Liu [38] with a few modifications [39]. DNA
was resuspended in 50 μl of TE buffer containing 10 mM
Tris, and 1 mM EDTA (pH 8) and separated by electro-
phoresis on 0.8% agarose gel for 4 hours at 4 Volt/cm.
Plasmids of known sizes isolated from E. coli V517 and
39R861 were used as controls.
PFGE
Selection of strains used for genotypic analysis was based
on location and year of isolation and antibiotic resistance
profiles. PFGE was performed using the Pulsenet recom-
mended procedure [40]. The plugs containing agarose-
embedded DNA were digested with 50 Units of SfiI (40
Units/μL) or NotI (10 Units/μL). Fragments from Xba1-
digested Salmonella Braenderup H9812 were used as
molecular size markers.
Results and discussion
Antibiotic susceptibility tests and conjugation tests
All the 65 strains showing resistance to the Chl-Strep-Sul-
Trim combinations transferred this phenotype to E. coli
C600 en bloc. The frequency of transfer, expressed as
number of transconjugants per recipients, ranged betweenPage 4 of 8
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analysis of the donor strains and the E. coli C600 transcon-
jugants amplified a 626 bp fragment of sulII gene encod-
ing resistance to sulfamethoxazole, a 278 bp amplicon
corresponding to the dfrA1 gene encoding resistance to tri-
methoprim, a 515 bp fragment of strB encoding resistance
to streptomycin, a 526 bp fragment of floR gene conferring
resistance to chloramphenicol and a 1035 bp fragment
corresponding to the integrase gene of the SXT/R391 ICE
family, thus confirming co-transfer of resistance markers
and this element. The trpM gene of the transposon Tn21
was not detected in the transconjugants indicating that
this transposon had not been acquired via conjugation.
The dfrA18 gene was not detected in any of the isolates
analysed. Similarly, attempts to isolate plasmids in the
donor strains and transconjugants were not successful.
These results are in agreement with those obtained by
Pugliese et al. [7] who demonstrated the co-transfer of the
SXT-like element with the genes encoding the Chl-Strep-
Sul-Trim phenotype in O1 strains isolated locally in dur-
ing the 1998-1999. These workers also found that some
strains had an incC plasmid harbouring a gene conferring
resistance to tetracycline and while other strains were
resistant to ampicillin but we did not identify any strain in
our collection bearing these resistance patterns. V. cholerae
O1 strains resistant to tetracycline have previously been
reported in Kenya [6] and Zambia [41] in the 1990s, but
those isolated from Ethiopia [42] and Somalia [43] in the
same period were susceptible to this antibiotic. Further-
more, strains isolated from previous outbreaks in Kenya
were known to exhibit resistance to ampicillin [7], doxy-
cycline and streptomycin [44]. None of the strains we
studied were resistant to furazolidone as was the case with
strains isolated from Mozambican immigrants in South
Africa [45]. Similarly, none of these strains were resistant
to ceftriaxone, cefotaxime, nalidixic acid, amikacin and
gentamicin as has been the case with strains previously
reported from Ghana [46]. All the strains we analysed also
lacked the dfrA18 gene encoding resistance to trimetho-
prim in O1 and non-O1 strains isolated in India [47].
Genetic and environmental factors that may be responsi-
ble for the apparent serotype shift from Ogawa to Inaba in
recent outbreaks in Kenya remain to be elucidated. While
strains that do not harbour the SXT/R391-like element
and those bearing the incC plasmids were not available
for analysis alongside those included in our study, it is
apparent that the gradual emergence of a population of V.
cholerae O1 strains bearing the SXT/R391-like element as
a major cause of cholera outbreaks in Kenya has occurred
independent of antibiotic resistance acquisition.
It remains to be determined exactly when the SXT/R391-
like ICE emerged in pathogenic V. cholera strains in Kenya
because isolates obtained locally between 1975 and 1983
were known to exhibit resistance to antibiotics encoun-
tered in the Chl-Strep-Sul-Trim phenotype [5,6] that has
lately been associated to the presence of the SXT-type ICEs
[12]. Although it is well established that cholera came to
Africa from Asia in the 1970s, it is only suspected that the
SXT-like elements have been present in African Vibrio spp
even before the emergence of the V. cholerae O139 from
which the first SXT element, SXTMO10, was identified [12].
ICE-like elements have been detected in O1 clinical
strains isolated in 1992 in Angola and V. parahaemolyticus
clinical strains from the same country isolated in 1991
were also shown to contain SXT-related ICEs that do not
mediate resistance to antibiotics [14]. Similarly, analysis
of O1 El Tor clinical isolates from Algeria isolated in 1994
suggests the presence of SXT-like ICEs mediating trimeth-
oprim resistance [48]. However, the isolates from the
1994 outbreak in the Goma refugee camp in Zaire did not
harbour this element [13]. Our study demonstrates that
the O1 El Tor strains bearing the SXT/R391-like ICE were
in circulation in Kenya in the 1994-1996 period and have
continued to persist in recent outbreaks. This may suggest
that the 6 strains isolated from the two outbreaks in 1994-
1996 in Kwale, a coastal town of Kenya, are some of the
oldest strains in the region known to harbour this inte-
grating conjugative element in this part of the continent.
Analysis for mobile genetic elements and Vibrio cholerae 
Pathogenicity Island
All the 65 O1 strains were positive for all the V. cholerae
pathogenic genes except for the NAG-specific heat-stable
toxin (st). These strains were also positive for the IntI4
integrase belonging to integron class 4, asuper-integron
believed to be important in shuffling the Vibrio cholerae
genome [25]. It is worth noting that the st gene normally
occurs as a cassette (sto) within Int4 region in some V. chol-
erae strains but not in others [26]. Besides the st gene,
another pathogenicity determinant, mrhA, is frequently
detected in SI region of O1 and non-O1strains [49]. It is
not clear whether the presence of the st gene improves bio-
logical fitness of the host but appears to be dispensable
without compromising the ability to cause disease in
pathogenic strains.
Besides the SXT elements, other mobile genetic elements
implicated in the spread of antibiotic resistance pheno-
type in V. cholerae from Africa include conjugative plas-
mids belonging to class C [5,7], integron class 1 [41,46],
and integron class 2 [41]. Although the isolates we studied
carried the SXT element, they lacked the class 1, 2, and 3
integrons and did not harbour any conjugative plasmids.
All the strains were negative for the transposase gene
belonging to Tn7 but were positive for the trpM gene asso-
ciated with Tn21. The Tn7 has frequently been detected in
gram negative strains containing integron class 2 [26]. On
the other hand, Tn21 and its relatives are major agents inPage 5 of 8
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resistance genes in gram negative bacteria but not all
Tn21-like transposons are associated with antibiotic
resistance and there are variations in the diversity of anti-
biotic resistance genes detected in Tn21-like transposons
that harbour antibiotic resistance markers [50]. PCR anal-
ysis of transconjugants did not detect the Tn21 implying
that this transposon was not co-transferred with the SXT/
R391-like element during conjugation. We were however
not able to determine if this element confers mercury
resistance to the strains we studied or if it is physically
linked to any antibiotic resistance markers. It is also not
clear if this transposon has all the other genes responsible
for transposition such as tnpA, tnpR, res, and inverted
repeats or if it exists as a defective transposon in these
strains. However, the presence of the trpM gene suggests
that although the strains carrying the SXT/R391-like ele-
ments lack multiple resistant integrons, this transposon is
genetically ready to accept such elements because inte-
grons are normally located adjacent to this gene [50]. It
has been suggested that Tn21-like transposons which con-
fer multiple antibiotic resistance descended from an
ancestral mercury resistance transposon like Tn501 by
successive insertions of antibiotic resistances and/or inser-
tion sequences [51]. It is therefore important to further
characterize Tn21 in pathogenic V. cholerae strains.
All the 65 strains were positive for the CTXETΦ but nega-
tive for all the other CTXΦ phage repressor gene alleles
and this contradicts with the study on O1 El Tor strains
isolates from Mozambique [52] and India [20] which
have been reported to harbour the CTXclassΦ repressor.
Such El Tor Strains carrying the CTXclassΦ repressor are
now designated as the Matlab variants of V. cholerae [53].
Our finding on the diversity of the CTXETΦ repressor and
the absence of the other rstR genes in all the strains further
indicate the need for detailed studies on the genetic diver-
sity of V. cholerae strains from different parts of the conti-
nent to gain insight into the evolutionary trends of V.
cholerae species causing epidemics in Africa.
Pulsed Field Gel Electrophoresis
Analysis of macro-restricted DNA using Not1 demon-
strated that all the SXT-carrying strains produced indistin-
guishable digest patterns regardless of the year and region
of isolation (Figure 2). Similarly, restriction digest analy-
sis using Sfi1 showed that all strains were clonal (data not
shown). The fact that all our strains showed identical pat-
tern in antibiotic susceptibility patterns, pathogenicity
genes, and the diversity of mobile genetic elements
strongly suggest that this population of O1 strains that
have caused outbreaks since 1994 to as recent as 2007 are
clonally related. The absence of the st gene (which is com-
mon among non-01 and non-0139 strains) [19] and the
absence of the classical biotype-specific tcpA and hylA
genes in these strains further indicates that genetic
exchanges between this population and other V. cholerae
serotypes that might be in circulation in Kenya have been
highly restricted. In a previous study by Jiang et al. [54] it
was noted that a number of O1 strains from Kenya failed
to cluster with those isolated from other parts of the world
when using Amplified Fragment Length Polymorphism
(AFLP) genotyping technique. Similarly, the study by
Pugliese et al. [7] showed that strains that carried the SXT-
element alone or in combination with an incC plasmid
belonged to a unique RAPD cluster IV. In the same study
[7], strains without this ICE were shown to belong to
other cluster types shared by isolates from Ethiopia and
Somali. It is also interesting to note that none of the iso-
lates from 1998-1999 study shared a RAPD cluster with
strains isolated in India and Bahrain isolated in 1948 and
1978. Such observations have led to a theory that some
toxigenic V. cholerae strains circulating in different coun-
tries may not have originated from a single clone in Asia
as is popularly believed, but may have been derived
locally from genetic exchange between the Asian O1
strains and the O1 or non-O1 strains from local environ-
ments [54].
PFGE of Not1 digested genomic DNA of V. Inaba strains iso-lated from various regions f Kenya between 1994 and 2007Figure 2
PFGE of Not1 digested genomic DNA of V. Inaba 
strains isolated from various regions of Kenya 
between 1994 and 2007. Genomic DNA from representa-
tive strains was digested with Not1 restriction enzyme and 
loaded as follows; M: molecular weight marker (S. 
Braenderup), Kw: Kwale, Sy: Siaya, Mn: Malindi, Mk: 
Makindu, Nr: Nairobi, Kb: Kibwezi, Mo: Mombasa, Bu: 
Busia, Kf: Kilifi, Ka: Kakuma, Da: Daadab, Ma; Mandera. The 
year when each of the isolate included in this experiment are 
also indicated.
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We observed that antibiotic susceptibility and genomic
content of the strains bearing the SXT/R391-like ICE that
have been in circulation in Kenya between 1994 and 2007
has not changed significantly and there are indications
that these strains have undergone minimum genotypic
changes during this entire period. In the absence of older
isolates for molecular characterization, it is not possible to
determine whether other clones of V. cholerae bearing this
ICE have existed in Kenya and is also difficult to deter-
mine when the SXT/R391-bearing clone emerged as the
major cause of outbreaks in Kenya. In order to understand
the epidemiological trends of cholera outbreaks in the
region, there is need for further studies to determine evo-
lutionary trends among strains isolated from the African
region and compare them with those from other parts of
the world.
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